These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 29253843

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
    Green CE, Vayalapra S, Hampson JA, Mukherjee D, Stockley RA, Turner AM.
    Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL, Lin CH.
    Int J Chron Obstruct Pulmon Dis; 2016 Oct; 11():2341-2348. PubMed ID: 27703344
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency.
    Banga A, Gildea T, Rajeswaran J, Rokadia H, Blackstone EH, Stoller JK.
    Am J Respir Crit Care Med; 2014 Aug 01; 190(3):274-81. PubMed ID: 25003824
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
    Stoller JK, Aboussouan LS, Kanner RE, Wilson LA, Diaz P, Wise R, LOTT Research Group.
    Ann Am Thorac Soc; 2015 Dec 01; 12(12):1796-804. PubMed ID: 26653189
    [Abstract] [Full Text] [Related]

  • 12. Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZ.
    Bernhard N, Lepper PM, Vogelmeier C, Seibert M, Wagenpfeil S, Bals R, Fähndrich S.
    Respir Med; 2017 Sep 01; 130():1-8. PubMed ID: 29206626
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association between COPD exacerbations and lung function decline during maintenance therapy.
    Kerkhof M, Voorham J, Dorinsky P, Cabrera C, Darken P, Kocks JW, Sadatsafavi M, Sin DD, Carter V, Price DB.
    Thorax; 2020 Sep 01; 75(9):744-753. PubMed ID: 32532852
    [Abstract] [Full Text] [Related]

  • 16. Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up.
    Pignatti P, Visca D, Zappa M, Zampogna E, Saderi L, Sotgiu G, Centis R, Migliori GB, Spanevello A.
    BMC Pulm Med; 2024 May 19; 24(1):247. PubMed ID: 38764008
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relationship of the 2011 Global Initiative for Chronic Obstructive Lung Disease strategy to clinically relevant outcomes in individuals with α1-antitrypsin deficiency.
    Pillai AP, Turner AM, Stockley RA.
    Ann Am Thorac Soc; 2014 Jul 19; 11(6):859-64. PubMed ID: 24950156
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.